Microbot Medical (MBOT) Accumulated Expenses (2010 - 2026)

Microbot Medical has reported Accumulated Expenses for 17 years, with the latest figure at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 22.33% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (up 22.33% YoY), and the FY2025 full-year result was $2.6 million, up 17.48% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $2.0 million, down from $2.6 million in the prior quarter.
• The five-year high for Accumulated Expenses was $2.6 million in Q4 2025, with the low at $743000.0 in Q1 2023.
• Historically, Accumulated Expenses has averaged $1.4 million across 5 years, with a median of $1.1 million in 2022.
• Annual changes were most pronounced in 2023 — Accumulated Expenses tumbled 35.22% — and 2024, when it jumped 116.65%.
• Microbot Medical's Accumulated Expenses stood at $1.4 million in 2022, then retreated by 25.15% to $1.0 million in 2023, then jumped by 116.65% to $2.2 million in 2024, then advanced by 17.48% to $2.6 million in 2025, then slipped by 24.33% to $2.0 million in 2026.
• The last three Accumulated Expenses figures came in at $2.0 million (Q1 2026), $2.6 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.